4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings
August 22, 2017 at 13:02 PM EDT
The second half of 2017 is expected to be catalyst rich for quite a few companies with data expected across a wide range of therapeutics areas.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.